Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression

The dynamic and interactive tumor microenvironment is conceived as a considerable parameter in tumor development and therapy response. Implementing this knowledge in the development of future cancer treatments could provide novel options in the combat of highly aggressive and difficult-to-treat tumo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eisemann, Tanja (VerfasserIn) , Costa, Barbara (VerfasserIn) , Peterziel, Heike (VerfasserIn) , Angel, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 March 2019
In: Frontiers in oncology
Year: 2019, Jahrgang: 9
ISSN:2234-943X
DOI:10.3389/fonc.2019.00187
Online-Zugang:Verlag, Volltext: https://doi.org/10.3389/fonc.2019.00187
Volltext
Verfasserangaben:Tanja Eisemann, Barbara Costa, Heike Peterziel, Peter Angel

MARC

LEADER 00000caa a2200000 c 4500
001 1666382884
003 DE-627
005 20220816162156.0
007 cr uuu---uuuuu
008 190528s2019 xx |||||o 00| ||eng c
024 7 |a 10.3389/fonc.2019.00187  |2 doi 
035 |a (DE-627)1666382884 
035 |a (DE-599)KXP1666382884 
035 |a (OCoLC)1341225629 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eisemann, Tanja  |e VerfasserIn  |0 (DE-588)115665744X  |0 (DE-627)1020125454  |0 (DE-576)502351357  |4 aut 
245 1 0 |a Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression  |c Tanja Eisemann, Barbara Costa, Heike Peterziel, Peter Angel 
264 1 |c 26 March 2019 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.05.2019 
520 |a The dynamic and interactive tumor microenvironment is conceived as a considerable parameter in tumor development and therapy response. Implementing this knowledge in the development of future cancer treatments could provide novel options in the combat of highly aggressive and difficult-to-treat tumors such as gliomas. One compartment of the tumor microenvironment that has gained growing interest is the immune system. As endogenous defense machinery the immune system has the capacity to fight against cancer cells. This, however, is frequently circumvented by tumor cells engaging immune-regulatory mechanisms that disable tumor-directed immune responses. Thus, in order to unlock the immune system against cancer cells, it is crucial to characterize in great detail individual tumor-associated immune cell subpopulations and dissect whether and how they influence immune evasion. In this study we investigated the function of a tumor-associated myeloid cell subpopulation characterized by podoplanin expression on the development of high-grade glioma tumors. Here, we show that the deletion of podoplanin in myeloid cells results in increased (CD8(+)) T-cell infiltrates and significantly prolonged survival in an orthotopic transplantation model. In vitro co-cultivation experiments indicate a podoplanin-dependent transcriptional regulation of arginase-1, a well-known player in myeloid cell-mediated immune suppression. These findings identify podoplanin positive myeloid cells as one novel mediator of the glioma-induced immune suppression. Thus, the targeted ablation of podoplanin positive myeloid cells could be included in combinatorial cancer therapies to enhance immune-mediated tumor elimination. 
650 4 |a arginase 
650 4 |a central-nervous-system 
650 4 |a clec-2 
650 4 |a expression 
650 4 |a glioblastoma 
650 4 |a glioblastoma patients 
650 4 |a immune evasion 
650 4 |a inflammation 
650 4 |a macrophages 
650 4 |a microenvironmental regulation 
650 4 |a microglia 
650 4 |a survival 
650 4 |a tumor immunology 
650 4 |a tumor microenvironment 
650 4 |a tumor-associated macrophages 
650 4 |a tumor-infiltrating lymphocytes 
700 1 |a Costa, Barbara  |e VerfasserIn  |0 (DE-588)1168422612  |0 (DE-627)1032224509  |0 (DE-576)511538774  |4 aut 
700 1 |a Peterziel, Heike  |e VerfasserIn  |0 (DE-588)1079032606  |0 (DE-627)840098022  |0 (DE-576)452152348  |4 aut 
700 1 |a Angel, Peter  |e VerfasserIn  |0 (DE-588)1080056572  |0 (DE-627)843623179  |0 (DE-576)453297668  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in oncology  |d Lausanne : Frontiers Media, 2011  |g Volume 9 (March 2019) Artikel-Nummer 187, Seite 1-10, 10 Seiten  |h Online-Ressource  |w (DE-627)684965518  |w (DE-600)2649216-7  |w (DE-576)35841184X  |x 2234-943X  |7 nnas  |a Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression 
773 1 8 |g volume:9  |g year:2019  |g extent:10  |a Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression 
856 4 0 |u  https://doi.org/10.3389/fonc.2019.00187  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190528 
993 |a Article 
994 |a 2019 
998 |g 1080056572  |a Angel, Peter  |m 1080056572:Angel, Peter  |d 50000  |e 50000PA1080056572  |k 0/50000/  |p 4  |y j 
998 |g 1079032606  |a Peterziel, Heike  |m 1079032606:Peterziel, Heike  |d 910000  |e 910000PP1079032606  |k 0/910000/  |p 3 
999 |a KXP-PPN1666382884  |e 3479897657 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune SuppressionFrontiers in oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"extent":"10","text":"Volume 9 (March 2019) Artikel-Nummer 187, Seite 1-10, 10 Seiten","year":"2019","volume":"9"},"language":["eng"],"pubHistory":["2011 -"],"note":["Gesehen am 07.11.13"],"id":{"zdb":["2649216-7"],"eki":["684965518"],"issn":["2234-943X"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Frontiers in oncology","title_sort":"Frontiers in oncology"}],"origin":[{"dateIssuedDisp":"2011-","publisher":"Frontiers Media","publisherPlace":"Lausanne","dateIssuedKey":"2011"}],"recId":"684965518"}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"26 March 2019"}],"title":[{"title":"Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression","title_sort":"Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}],"id":{"doi":["10.3389/fonc.2019.00187"],"eki":["1666382884"]},"recId":"1666382884","person":[{"display":"Eisemann, Tanja","given":"Tanja","role":"aut","family":"Eisemann"},{"family":"Costa","role":"aut","given":"Barbara","display":"Costa, Barbara"},{"role":"aut","family":"Peterziel","display":"Peterziel, Heike","given":"Heike"},{"given":"Peter","display":"Angel, Peter","role":"aut","family":"Angel"}],"note":["Gesehen am 28.05.2019"],"language":["eng"],"name":{"displayForm":["Tanja Eisemann, Barbara Costa, Heike Peterziel, Peter Angel"]}} 
SRT |a EISEMANNTAPODOPLANIN2620